Vascular endothelium: A vulnerable transit zone for merciless sodium

Nephrology Dialysis Transplantation

Volumn 29, Issue 2, 2014, Pages 440-446

  Oberleithner, Hans ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

blood vessel; glycocalyx; hypertension; salt sensitivity; sodium channels

Indexed keywords

ALDOSTERONE; ALDOSTERONE RECEPTOR; BIOPOLYMER; NITRIC OXIDE; SODIUM; SODIUM CHLORIDE; SODIUM CHANNEL;

ARTICLE; BLOOD VESSEL PERMEABILITY; ENDOTHELIUM; ERYTHROCYTE; EXTRACELLULAR MATRIX; GLYCOCALYX; HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SALT LOADING; SMOOTH MUSCLE TONE; SODIUM BLOOD LEVEL; VASCULAR ENDOTHELIUM; BLOOD VESSEL; CELL MEMBRANE PERMEABILITY; EXTRACELLULAR SPACE; HYPERTENSION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SALT SENSITIVITY; TRANSPORT AT THE CELLULAR LEVEL;

BLOOD VESSEL; GLYCOCALYX; HYPERTENSION; SALT SENSITIVITY; SODIUM CHANNELS;

BIOLOGICAL TRANSPORT; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; EXTRACELLULAR SPACE; GLYCOCALYX; HUMANS; HYPERTENSION; SODIUM; SODIUM CHLORIDE;

EID: 84907797279     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft461     Document Type: Article

References (72)

1. Meneton P, Jeunemaitre X, de Wardener HE et al. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85: 679-715
2. MacGregor G. Salt-Neptune's poisoned chalice. Trans Med Soc Lond 2002; 119: 13-14
3. Ritz E. Salt-friend or foe?. Nephrol Dial Transplant 2006; 21: 2052-2056
4. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27: 481-490
5. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science 1991; 252: 1813-1816
6. Kopp C, Linz P, Dahlmann A et al. 23Na Magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension 2013; 61: 635-640
7. Oberleithner H, Peters W, Kusche-Vihrog K et al. Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch 2011; 462: 519-528
8. Wehling M, Spes CH, Win N et al. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 1998; 83: 3517-3522
9. Nguyen Dinh CA, Jaisser F. Extrarenal effects of aldosterone. Curr Opin Nephrol Hypertens 2012; 21: 147-156
10. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension 2006; 47: 312-318
11. Oberleithner H, Ludwig T, Riethmuller C et al. Human endothelium: Target for aldosterone. Hypertension 2004; 43: 952-956
12. Funder JW. Minireview: Aldosterone and the cardiovascular system: Genomic and nongenomic effects. Endocrinology 2006; 147: 5564-5567
13. Jeong Y, Chaupin DF, Matsushita K et al. Aldosterone activates endothelial exocytosis. Proc Natl Acad Sci USA 2009; 106: 3782-3787
14. Kliche K, Jeggle P, Pavenstadt H et al. Role of cellular mechanics in the function and life span of vascular endothelium. Pflugers Arch 2011; 462: 209-217
15. Vestweber D. Novel insights into leukocyte extravasation. Curr Opin Hematol 2012; 19: 212-217
16. Versteeg HH, Heemskerk JW, Levi M et al. New fundamentals in hemostasis. Physiol Rev 2013; 93: 327-358
17. Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 2006; 176/I: 213-254
18. Oberleithner H, Riethmuller C, Schillers H et al. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA 2007; 104: 16281-16286
19. Golestaneh N, Klein C, Valamanesh F et al. Mineralocorticoid receptormediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 2001; 280: 1300-1306
20. Kusche-Vihrog K, Sobczak K, Bangel N et al. Aldosterone and amiloride alter ENaC abundance in vascular endothelium. Pflugers Arch 2008; 455: 849-857
21. Rossier BC, Canessa CM, Schild L et al. Epithelial sodium channels. Curr Opin Nephrol Hypertens 1994; 3: 487-496
22. Korte S,Wiesinger A, Straeter AS et al. Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis. Pflugers Arch 2012; 463: 269-278
23. Li J, White J, Guo L et al. Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 2009; 139: 447-451
24. Friedman SM, McIndoe RA, Tanaka M. The relation of blood sodium concentration to blood pressure in the rat. J Hypertens 1990; 8: 61-66
25. Santos SF, Peixoto AJ. Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 522-530
26. He FJ, Markandu ND, Sagnella GA et al. Plasma sodium: Ignored and underestimated. Hypertension 2005; 45: 98-102
27. Suckling RJ, He FJ, Markandu ND et al. Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int 2012; 81: 407-411
28. de Wardener HE. The hypothalamus and hypertension. Physiol Rev 2001; 81: 1599-1658
29. Blaustein MP, Leenen FH, Chen L et al. How NaCl raises blood pressure: A new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol 2012; 302: H1031-H1049
30. Blaustein MP, Zhang J, Chen L et al. The pump, the exchanger, and endogenous ouabain: Signaling mechanisms that link salt retention to hypertension. Hypertension 2009; 53: 291-298
31. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch 2000; 440: 653-666
32. Reitsma S, Slaaf DW, Vink H et al. The endothelial glycocalyx: Composition, functions, and visualization. Pflugers Arch 2007; 454: 345-359
33. Weinbaum S, Zhang X, Han Y et al. Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci USA 2003; 100: 7988-7995
34. Pries AR, Secomb TW, Jacobs H et al. Microvascular blood flow resistance: Role of endothelial surface layer. Am J Physiol 1997; 273: H2272-H2279
35. Oberleithner H. Two barriers for sodium in vascular endothelium?. Ann Med 2012; 44(Suppl 1): S143-S148
36. Tarbell JM, Ebong EE. The endothelial glycocalyx: A mechano-sensor and-Transducer. Sci Signal 2008; 1: T8
37. Nieuwdorp M, Meuwese MC, Vink H et al. The endothelial glycocalyx: A potential barrier between health and vascular disease. Curr Opin Lipidol 2005; 16: 507-511
38. Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009; 22: 155-162
39. Siegel G, Walter A, Kauschmann A et al. Anionic biopolymers as blood flow sensors. Biosens Bioelectron 1996; 11: 281-294
40. Bevan JA. Flow regulation of vascular tone. Its sensitivity to changes in sodium and calcium. Hypertension 1993; 22: 273-281
41. Chen W, Valamanesh F, Mirshahi T et al. Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells. Vascul Pharmacol 2004; 40: 269-277
42. Titze J, Machnik A. Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens 2010; 19: 385-392
43. Van Teeffelen JW, Brands J, Stroes ES et al. Endothelial glycocalyx: Sweet shield of blood vessels. Trends Cardiovasc Med 2007; 17: 101-105
44. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007; 9: 121-167
45. Curry FE, Adamson RH. Endothelial glycocalyx: Permeability barrier and mechanosensor. Ann Biomed Eng 2012; 40: 828-839
46. Vlahu CA, Lemkes BA, Struijk DG et al. Damage of the endothelial glycocalyx in dialysis patients. J Am Soc Nephrol 2012; 23: 1900-1908
47. Noble MI, Drake-Holland AJ, Vink H. Hypothesis: Arterial glycocalyx dysfunction is the first step in the atherothrombotic process. QJM 2008; 101: 513-518
48. Durocher JR, Payne RC, Conrad ME. Role of sialic acid in erythrocyte survival. Blood 1975; 45: 11-20
49. Vogt AM, Winter G, Wahlgren M et al. Heparan sulphate identified on human erythrocytes: A Plasmodium falciparum receptor. Biochem J 2004; 381: 593-597
50. Drzeniek Z, Stocker G, Siebertz B et al. Heparan sulfate proteoglycan expression is induced during early erythroid differentiation of multipotent hematopoietic stem cells. Blood 1999; 93: 2884-2897
51. Kobayashi K, Kato K, Sugi T et al. Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface. J Biol Chem 2010; 285: 1716-1725
52. Jan KM, Chien S. Influence of the ionic composition of fluid medium on red cell aggregation. J Gen Physiol 1973; 61: 655-668
53. Neu B, Sowemimo-Coker SO, Meiselman HJ. Cell-cell affinity of senescent human erythrocytes. Biophys J 2003; 85: 75-84
54. Hadengue AL, Del-Pino M, Simon A et al. Erythrocyte disaggregation shear stress, sialic acid, and cell aging in humans. Hypertension 1998; 32: 324-330
55. Oberleithner H. Vascular endothelium leaves fingerprints on the surface of erythrocytes. Pflügers Arch 2013; 465: 1451-1458
56. Shiu YT, McIntire LV. In vitro studies of erythrocyte-vascular endothelium interactions. Ann Biomed Eng 2003; 31: 1299-1313
57. Godin C, Caprani A. Interactions of erythrocytes with an artificial wall: Influence of the electrical surface charge. Eur Biophys J 1996; 25: 25-30
58. Vaziri ND. Oxidative stress in uremia: Nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473
59. Varez-Llamas G, Zubiri I, Maroto AS et al. A role for the membrane proteome in human chronic kidney disease erythrocytes. Transl Res 2012; 160: 374-383
60. Serroukh Y, Djebara S, Lelubre C et al. Alterations of the erythrocyte membrane during sepsis. Crit Care Res Pract 2012; 2012: 702956
61. Pot C, Chen AY, Ha JN et al. Proteolytic cleavage of the red blood cell glycocalyx in a genetic form of hypertension. Cell Mol Bioeng 2011; 4: 678-692
62. Hebbel RP, Moldow CF, Steinberg MH. Modulation of erythrocyte-endothelial interactions and the vasocclusive severity of sickling disorders. Blood 1981; 58: 947-952
63. Jan KM, Chien S. Role of surface electric charge in red blood cell interactions. J Gen Physiol 1973; 61: 638-654
64. Eylar EH, Madoff MA, Brody OV et al. The contribution of sialic acid to the surface charge of the erythrocyte. J Biol Chem 1962; 237: 1992-2000
65. Grzybowski A, Sak J. A short history of the discovery of the erythrocyte sedimentation rate. Int J Lab Hematol 2012; 34: 442-444
66. Sanada H, Jones JE, Jose PA. Genetics of salt-sensitive hypertension. Curr Hypertens Rep 2011; 13: 55-66
67. Hoffmann IS, Alfieri AB, Cubeddu LX. Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese saltsensitive Hispanics. J Hum Hypertens 2007; 21: 571-578
68. Oberleithner H, Wilhelmi M. Determination of erythrocyte sodium sensitivity in man. Pflugers Arch 2013; 465: 1459-1466
69. Brixius K, Willms S, Napp A et al. Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc Drugs Ther 2006; 20: 177-184
70. Peters W, Drueppel V, Kusche-Vihrog K et al. Nanomechanics and sodium permeability of endothelial surface layer modulated by hawthorn extractWS 1442. PLoS One 2012; 7: E29972
71. Oberleithner H. A physiological concept unmasking vascular salt sensitivity in man. Pflugers Arch 2012; 464: 287-293
72. Kusche-Vihrog K, Oberleithner H. An emerging concept of vascular salt sensitivity. F1000 Biol Rep 2012; 4: 20-27